gastric Cancer
Conditions
Interventions
Patients will be divided into 2 groups, an intervention group and a control group.
The intervention group will be composed of 53 patients who will receive the nutritional supplement high caloric and p
Dietary supplement
SP6.051.227
Sponsors
Instituto Nacional de Câncer
Instituto Nacional de Câncer
Eligibility
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: Target sample size is 106 patients. Patients with gastric cancer. Patients in pre-treatment (chemo / radiation / surgery). Female or male patients aged between 20 and 65 years. Signing of the Informed Consent.
Exclusion criteria
Exclusion criteria: Patients with Chronic Hepatic Insufficiency (CHILD-PUGH C); With HIV Virus or Acquired Immune Deficiency Syndrome (AIDS); Congestive Heart Failure Record; Chronic Kidney Disease; Diabetes Mellitus. Patients undergoing chemotherapy or radiotherapy already started. Patients with other cancer diagnosis in up to five years ago. Patients with focal infection or inflammatory disease. Patients who refuse to sign the consent form for study participation. Patients who did not tolerate the use of nutritional supplementation or do not use the supplement as prescribed amount i.e. adhesion to the lower supplementation to 80% prescribed amount.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The weight gain in the 30-day period, verified by weight before and after intervention , on a digital balance, from a variation of at least two kilos between measurements. | — |
Secondary
| Measure | Time frame |
|---|---|
| The lean mass gain in the 30-day period, verified by bioelectrical impedance before and after intervention from a range of 3% between measurements. | — |
Countries
Brazil
Contacts
Public ContactPatricia Feijó
Instituto Nacional de Câncer
Outcome results
None listed